Clinical Trials Matching Software Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Deployment Mode (Web & Cloud-based, On-premises), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), By Region, By Competition Forecast & Opportunities, 2018-2028F
Global Clinical Trials Matching Software Market has valued at USD 132.89 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.59% through 2028. Pharmaceutical companies, biotechnology firms, clinical research organizations (CROs), and medical device manufacturers routinely conduct clinical trials to assess the safety and efficacy of novel medications, diagnostic tools, and therapies. The increasing incidence of chronic illnesses and the escalating demand for clinical trials are anticipated to be driving factors behind market expansion. Moreover, clinical trials are progressively being conducted in emerging regions due to the critical importance of recruiting and matching patients effectively in these trials.
Key Market Drivers
Increasing Demand for Personalized Medicine
Personalized medicine has emerged as a transformative force in healthcare, offering tailored treatments based on an individual's genetic makeup, lifestyle, and unique health characteristics. This paradigm shift in medicine is not only revolutionizing patient care but also significantly impacting the pharmaceutical industry. The increasing demand for personalized medicine is driving a surge in clinical research and, in turn, is fueling the growth of the Global Clinical Trials Matching Software Market. Personalized medicine, also known as precision medicine, represents a fundamental shift from the traditional one-size-fits-all approach to medical treatment. It recognizes that each patient is unique, and their response to therapies can vary based on genetic, genomic, and molecular factors. This approach has been particularly successful in the treatment of cancer, where therapies are increasingly targeted to specific genetic mutations, leading to improved patient outcomes and reduced side effects. Personalized medicine relies on the identification of biomarkers and specific genetic variations associated with disease. This process involves extensive genetic profiling and molecular analysis, generating a wealth of data that needs to be tested in clinical trials. Clinical trials matching software plays a pivotal role in sifting through this vast data to identify suitable candidates for these trials, streamlining the recruitment process. The development of targeted therapies is at the heart of personalized medicine. These therapies are designed to act on specific molecular targets associated with a disease, making them more effective and reducing the risk of adverse effects. Clinical trials matching software helps identify patients who possess the target biomarkers, ensuring that the right individuals are enrolled in trials, thus increasing the chances of success. Personalized medicine often requires smaller, more focused clinical trials since patient populations are more narrowly defined. Clinical trials matching software aids in designing these trials efficiently by identifying and enrolling suitable participants quickly, reducing the time and cost of drug development. Patients are more likely to participate in clinical trials when they understand the potential benefits, especially when it comes to personalized treatments. Clinical trials matching software can provide patients with information about trials that align with their genetic profiles and medical histories, promoting patient engagement and recruitment. Genomic medicine, a subset of personalized medicine, relies heavily on genomic data and bioinformatics tools. Clinical trials matching software integrates seamlessly with genomic databases and can rapidly identify patients who meet the genetic criteria for these studies, expediting the translation of genomics into clinical practice.
Rising Complexity of Clinical Trials
Clinical trials are the cornerstone of modern healthcare, driving medical advancements and ensuring the safety and efficacy of new treatments. However, the landscape of clinical research has evolved significantly, with trials becoming increasingly intricate and data intensive. This transformation has led to a growing demand for sophisticated tools to streamline patient recruitment and study management. The traditional clinical trial model, which involved a straightforward process of enrolling patients, administering treatments, and recording outcomes, has given way to a more intricate and data-driven paradigm. Several factors contribute to the growing complexity of clinical trials. Clinical trials are now conducted on diverse patient populations, including those with rare diseases, specific genetic mutations, or distinct demographic characteristics. Identifying suitable candidates within these subgroups demands precise patient matching. To expedite drug development and optimize outcomes, multi-arm and adaptive trials are becoming more common. These trials involve multiple treatment arms, complex randomization algorithms, and dynamic adjustments based on emerging data. The integration of real-world data, including electronic health records (EHRs), wearable device data, and patient-reported outcomes, has become crucial for generating meaningful insights during clinical trials. Biomarker-driven trials and the use of novel clinical endpoints require intricate data analysis and a keen understanding of genetic and molecular markers. Clinical trials matching software leverages artificial intelligence (AI) and machine learning (ML) algorithms to analyze vast datasets, including patient records, genomic data, and real-world evidence. This ensures the rapid and accurate identification of eligible participants. Complex trials often require the identification of specific patient subgroups. Matching software can pinpoint individuals with unique characteristics or biomarkers, enabling precise recruitment. By automating the screening and enrollment processes, clinical trials matching software reduces administrative burden, allowing trial coordinators to focus on strategic protocol optimization. For adaptive trials, these software solutions can adapt and modify patient recruitment criteria and randomization based on real-time data, ensuring efficient trial execution.
Advancements in Technology
Advancements in technology have been reshaping industries across the board, and the healthcare sector is no exception. In particular, the Global Clinical Trials Matching Software Market is experiencing remarkable growth, propelled by the transformative power of modern technology. AI and ML are at the forefront of technological innovations in healthcare. These technologies have significantly enhanced the capabilities of clinical trials matching software. Machine learning algorithms can analyze vast amounts of patient data, electronic health records (EHRs), and historical trial data to identify suitable candidates for clinical trials more efficiently and accurately than ever before. This not only accelerates patient recruitment but also increases the likelihood of trial success. The healthcare industry generates massive amounts of data daily, from patient records to genomics information. Advanced data analytics tools can sift through this data to uncover patterns, identify potential trial participants, and predict trial outcomes. This data-driven approach is instrumental in optimizing the clinical trial process. Wearable devices and the Internet of Things (IoT) have opened up new possibilities in clinical research. Patient data collected in real-time through wearables, such as heart rate monitors and activity trackers, can be seamlessly integrated into clinical trials matching software. This provides a continuous stream of valuable data, aiding in patient monitoring and adherence to trial protocols. Data security and transparency are paramount in clinical trials. Blockchain technology ensures the immutability and security of trial data, maintaining the integrity of the research process. It also streamlines data sharing among stakeholders while protecting patient privacy. Telemedicine and remote monitoring solutions have become indispensable, especially in the context of global clinical trials. These technologies enable remote patient participation, reducing geographical constraints and expanding the pool of potential trial candidates. VR and AR are being employed in clinical trial design and patient engagement. Virtual simulations can help researchers visualize trial protocols, while AR applications can improve patient understanding and adherence to study requirements. Advanced technology enables clinical trials matching software to process vast datasets quickly and accurately, reducing the time and cost of patient recruitment. This efficiency is especially crucial in rare disease trials, where finding eligible participants can be challenging. Technology-driven solutions help identify patients who are most likely to benefit from personalized medicine approaches, such as targeted therapies based on genetic markers. Clinical trials matching software assists in connecting patients with tailored treatments. The integration of technology ensures the secure, transparent, and efficient management of clinical trial data, complying with stringent regulatory requirements. This boosts confidence among stakeholders and regulatory bodies. Technology facilitates global collaboration in clinical research. Researchers and institutions from different parts of the world can work together seamlessly, expanding the reach and diversity of clinical trials.
Global Pandemic and Vaccine Development
The global pandemic caused by COVID-19 has been an unprecedented global challenge, but it has also accelerated innovation in healthcare and drug development. The rapid development and distribution of vaccines have highlighted the critical role of clinical trials and their matching software. The development of multiple COVID-19 vaccines in record time showcased the importance of expeditious clinical trial recruitment. Clinical trials matching software played a crucial role in quickly identifying and enrolling suitable candidates for vaccine trials, hastening the vaccine development process. COVID-19 clinical trials needed to include a diverse range of participants to ensure the effectiveness of vaccines across various demographics. Matching software helped identify and engage individuals from different age groups, ethnicities, and health conditions, contributing to robust vaccine data. In the wake of the pandemic, remote patient recruitment and engagement became essential. Clinical trials matching software enabled potential participants to connect with trials, access trial information, and complete pre-screening assessments from the safety of their homes. As the pandemic unfolded, real-world evidence became increasingly valuable in understanding disease progression and treatment outcomes. Matching software integrated real-world data sources, such as electronic health records, to identify potential trial participants based on their medical history and COVID-19 exposure. The FDA and other regulatory agencies issued EUAs for COVID-19 treatments and vaccines based on limited data. Clinical trials matching software helped identify patients who could potentially benefit from these treatments and provided real-world data to support EUA decisions. The pandemic heightened awareness of the importance of clinical trials and matching software. This increased recognition is expected to drive continued adoption of these technologies even after the pandemic subsides. Telemedicine and remote patient engagement, which became crucial during the pandemic, will continue to be integrated into clinical trials. Matching software will play a pivotal role in connecting patients with trials while ensuring remote monitoring and data collection. The experience gained during the pandemic will better prepare the healthcare industry to respond quickly to future health crises. Clinical trials matching software will remain an essential tool for accelerating trial recruitment. Patients have become more proactive in seeking clinical trial opportunities, and matching software will continue to empower them with information and access to trials that align with their health profiles.
Key Market Challenges
Data Privacy and Security Concerns
One of the foremost challenges in the clinical trials matching software market pertains to data privacy and security. Handling sensitive patient data, including medical records and genetic information, requires stringent adherence to privacy regulations such as HIPAA in the United States and GDPR in Europe. Ensuring data security and complying with these regulations can be a complex and costly endeavor for software providers.
Interoperability with Healthcare Systems
Integrating clinical trials matching software with existing healthcare systems, including electronic health records (EHRs), is essential for efficient patient recruitment. However, achieving seamless interoperability remains a significant challenge due to diverse data formats, system compatibility issues, and varying standards across healthcare organizations.
Regulatory Compliance
The clinical trials industry is subject to strict regulatory oversight by agencies like the FDA and EMA. Clinical trials matching software must adhere to evolving regulatory requirements, including data integrity, audit trails, and electronic signatures. Achieving and maintaining compliance can be resource-intensive for software providers.
Ethical Considerations
The ethical aspects of patient recruitment are critical. Ensuring informed consent, minimizing potential biases in participant selection, and addressing disparities in access to trials are ethical challenges faced by clinical trials matching software providers. Ethical considerations also extend to ensuring that patients fully understand the implications of trial participation.
Key Market Trends
Artificial Intelligence and Machine Learning Integration
The integration of artificial intelligence (AI) and machine learning (ML) is set to be a defining trend in the clinical trials matching software market. AI algorithms are becoming increasingly adept at processing vast datasets, identifying potential trial candidates, and predicting patient responses to treatments. ML-driven tools will streamline patient recruitment and optimize trial designs, ultimately accelerating drug development.
Real-Time Data Analytics
The demand for real-time data analytics in clinical trials is growing rapidly. Clinical trials matching software is evolving to provide researchers with immediate access to trial data, allowing them to make data-driven decisions in real time. This trend will enhance the agility and efficiency of clinical trials.
Patient-Centric Approach
A patient-centric approach is gaining prominence in clinical research. Upcoming trends in clinical trials matching software will prioritize patient engagement and empowerment. Patients will have improved access to trial information, simplified enrollment processes, and tools to monitor their progress throughout the trial.
Genomics and Precision Medicine
The era of precision medicine is firmly upon us. As genomics becomes more central to healthcare, clinical trials matching software will incorporate genetic and molecular data to identify candidates for trials tailored to specific genetic profiles. This trend will be particularly significant in oncology and rare disease research.
Segmental Insights
Deployment Mode Insights
Based on the category of Deployment Mode, the web and cloud sector dominated the revenue share in 2022 and is anticipated to experience the most rapid CAGR during the forecast period. This can be attributed to the advantages of the cloud computing model, which is low-maintenance and doesn't entail ongoing expenses. Since it doesn't necessitate in-house server infrastructure, it leads to reduced development costs, shorter integration times, and accessibility from any location. It also facilitates convenient data sharing and collaboration on diverse projects. In contrast, the on-premises model demands in-house infrastructure, software licensing, IT support, and lengthier integration periods, making it a more expensive and less favored option. However, organizations dealing with highly sensitive data, such as government and financial institutions, may prioritize the security and privacy offered by an on-premises environment.
End-use Insights
The pharmaceutical and biotechnology companies sector secured the largest share of revenue due to the extensive number of clinical trials necessary for product launches. To illustrate, in the United States, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) mandates that pharmaceutical companies must conduct safety and efficacy tests on their drugs and provide evidence to the center before selling them in the country. This evaluation process aids in evaluating the advantages and potential risks associated with these medications.
Concurrently, the Contract Research Organization (CRO) segment is projected to achieve the most rapid CAGR over the forecast period. CROs offer a range of services from drug development to commercialization, pharmacovigilance, and post-approval support for manufacturing organizations operating with limited Research and Development (R&D) budgets. Sponsors, the entities seeking to investigate the safety and effectiveness of their products, engage CROs on a project-by-project basis for conducting clinical trials. Organizations that cannot afford to conduct extensive clinical trials themselves increasingly opt to outsource these services. Consequently, there is a surging demand for CROs in the market.
Regional Insights
In 2022, North America took the lead in the market, securing the highest revenue share. This can be attributed to the increased adoption of clinical trials matching software by pharmaceutical and biotechnology companies in the United States. Additionally, the region boasts a robust and well-established pharmaceutical industry, with many companies investing in the development of clinical trials matching software, which is a key driver of market growth. Furthermore, the regulatory environment in North America is conducive to the advancement and commercialization of clinical trial matching software. Various initiatives related to Information Technology (IT) and Artificial Intelligence (AI)-based solutions, coupled with a higher adoption of Clinical Trial Management Systems (CTMS) and patient matching software, are contributing to market expansion in the region.
Conversely, the Asia Pacific region is poised to experience the swiftest CAGR in the upcoming forecast period. This is primarily due to the presence of a substantial patient pool in the region, which facilitates streamlined patient recruitment processes. A multitude of organizations are also looking to establish their Research and Development (R&D) activities in the Asia Pacific, further bolstering market growth. This growth can be attributed to the increasing number of IT healthcare projects, the flourishing economy, and an overall enhancement of healthcare infrastructure, particularly in developing Asian countries such as China and India.
Key Market Players
IBM Clinical Development
Antidote Technologies Inc
Ofni Systems Inc
SSS International Clinical Research GmbH
CLARIO
Advarra Inc
ArisGlobal LLC
Bsi Business Systems Integration AG
Teckro Ltd
Clinical Trials Mobile Application
Report Scope:
In this report, the Global Clinical Trials Matching Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trials Matching Software Market.
Available Customizations:
Global Clinical Trials Matching Software market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
Increasing Demand for Personalized Medicine
Personalized medicine has emerged as a transformative force in healthcare, offering tailored treatments based on an individual's genetic makeup, lifestyle, and unique health characteristics. This paradigm shift in medicine is not only revolutionizing patient care but also significantly impacting the pharmaceutical industry. The increasing demand for personalized medicine is driving a surge in clinical research and, in turn, is fueling the growth of the Global Clinical Trials Matching Software Market. Personalized medicine, also known as precision medicine, represents a fundamental shift from the traditional one-size-fits-all approach to medical treatment. It recognizes that each patient is unique, and their response to therapies can vary based on genetic, genomic, and molecular factors. This approach has been particularly successful in the treatment of cancer, where therapies are increasingly targeted to specific genetic mutations, leading to improved patient outcomes and reduced side effects. Personalized medicine relies on the identification of biomarkers and specific genetic variations associated with disease. This process involves extensive genetic profiling and molecular analysis, generating a wealth of data that needs to be tested in clinical trials. Clinical trials matching software plays a pivotal role in sifting through this vast data to identify suitable candidates for these trials, streamlining the recruitment process. The development of targeted therapies is at the heart of personalized medicine. These therapies are designed to act on specific molecular targets associated with a disease, making them more effective and reducing the risk of adverse effects. Clinical trials matching software helps identify patients who possess the target biomarkers, ensuring that the right individuals are enrolled in trials, thus increasing the chances of success. Personalized medicine often requires smaller, more focused clinical trials since patient populations are more narrowly defined. Clinical trials matching software aids in designing these trials efficiently by identifying and enrolling suitable participants quickly, reducing the time and cost of drug development. Patients are more likely to participate in clinical trials when they understand the potential benefits, especially when it comes to personalized treatments. Clinical trials matching software can provide patients with information about trials that align with their genetic profiles and medical histories, promoting patient engagement and recruitment. Genomic medicine, a subset of personalized medicine, relies heavily on genomic data and bioinformatics tools. Clinical trials matching software integrates seamlessly with genomic databases and can rapidly identify patients who meet the genetic criteria for these studies, expediting the translation of genomics into clinical practice.
Rising Complexity of Clinical Trials
Clinical trials are the cornerstone of modern healthcare, driving medical advancements and ensuring the safety and efficacy of new treatments. However, the landscape of clinical research has evolved significantly, with trials becoming increasingly intricate and data intensive. This transformation has led to a growing demand for sophisticated tools to streamline patient recruitment and study management. The traditional clinical trial model, which involved a straightforward process of enrolling patients, administering treatments, and recording outcomes, has given way to a more intricate and data-driven paradigm. Several factors contribute to the growing complexity of clinical trials. Clinical trials are now conducted on diverse patient populations, including those with rare diseases, specific genetic mutations, or distinct demographic characteristics. Identifying suitable candidates within these subgroups demands precise patient matching. To expedite drug development and optimize outcomes, multi-arm and adaptive trials are becoming more common. These trials involve multiple treatment arms, complex randomization algorithms, and dynamic adjustments based on emerging data. The integration of real-world data, including electronic health records (EHRs), wearable device data, and patient-reported outcomes, has become crucial for generating meaningful insights during clinical trials. Biomarker-driven trials and the use of novel clinical endpoints require intricate data analysis and a keen understanding of genetic and molecular markers. Clinical trials matching software leverages artificial intelligence (AI) and machine learning (ML) algorithms to analyze vast datasets, including patient records, genomic data, and real-world evidence. This ensures the rapid and accurate identification of eligible participants. Complex trials often require the identification of specific patient subgroups. Matching software can pinpoint individuals with unique characteristics or biomarkers, enabling precise recruitment. By automating the screening and enrollment processes, clinical trials matching software reduces administrative burden, allowing trial coordinators to focus on strategic protocol optimization. For adaptive trials, these software solutions can adapt and modify patient recruitment criteria and randomization based on real-time data, ensuring efficient trial execution.
Advancements in Technology
Advancements in technology have been reshaping industries across the board, and the healthcare sector is no exception. In particular, the Global Clinical Trials Matching Software Market is experiencing remarkable growth, propelled by the transformative power of modern technology. AI and ML are at the forefront of technological innovations in healthcare. These technologies have significantly enhanced the capabilities of clinical trials matching software. Machine learning algorithms can analyze vast amounts of patient data, electronic health records (EHRs), and historical trial data to identify suitable candidates for clinical trials more efficiently and accurately than ever before. This not only accelerates patient recruitment but also increases the likelihood of trial success. The healthcare industry generates massive amounts of data daily, from patient records to genomics information. Advanced data analytics tools can sift through this data to uncover patterns, identify potential trial participants, and predict trial outcomes. This data-driven approach is instrumental in optimizing the clinical trial process. Wearable devices and the Internet of Things (IoT) have opened up new possibilities in clinical research. Patient data collected in real-time through wearables, such as heart rate monitors and activity trackers, can be seamlessly integrated into clinical trials matching software. This provides a continuous stream of valuable data, aiding in patient monitoring and adherence to trial protocols. Data security and transparency are paramount in clinical trials. Blockchain technology ensures the immutability and security of trial data, maintaining the integrity of the research process. It also streamlines data sharing among stakeholders while protecting patient privacy. Telemedicine and remote monitoring solutions have become indispensable, especially in the context of global clinical trials. These technologies enable remote patient participation, reducing geographical constraints and expanding the pool of potential trial candidates. VR and AR are being employed in clinical trial design and patient engagement. Virtual simulations can help researchers visualize trial protocols, while AR applications can improve patient understanding and adherence to study requirements. Advanced technology enables clinical trials matching software to process vast datasets quickly and accurately, reducing the time and cost of patient recruitment. This efficiency is especially crucial in rare disease trials, where finding eligible participants can be challenging. Technology-driven solutions help identify patients who are most likely to benefit from personalized medicine approaches, such as targeted therapies based on genetic markers. Clinical trials matching software assists in connecting patients with tailored treatments. The integration of technology ensures the secure, transparent, and efficient management of clinical trial data, complying with stringent regulatory requirements. This boosts confidence among stakeholders and regulatory bodies. Technology facilitates global collaboration in clinical research. Researchers and institutions from different parts of the world can work together seamlessly, expanding the reach and diversity of clinical trials.
Global Pandemic and Vaccine Development
The global pandemic caused by COVID-19 has been an unprecedented global challenge, but it has also accelerated innovation in healthcare and drug development. The rapid development and distribution of vaccines have highlighted the critical role of clinical trials and their matching software. The development of multiple COVID-19 vaccines in record time showcased the importance of expeditious clinical trial recruitment. Clinical trials matching software played a crucial role in quickly identifying and enrolling suitable candidates for vaccine trials, hastening the vaccine development process. COVID-19 clinical trials needed to include a diverse range of participants to ensure the effectiveness of vaccines across various demographics. Matching software helped identify and engage individuals from different age groups, ethnicities, and health conditions, contributing to robust vaccine data. In the wake of the pandemic, remote patient recruitment and engagement became essential. Clinical trials matching software enabled potential participants to connect with trials, access trial information, and complete pre-screening assessments from the safety of their homes. As the pandemic unfolded, real-world evidence became increasingly valuable in understanding disease progression and treatment outcomes. Matching software integrated real-world data sources, such as electronic health records, to identify potential trial participants based on their medical history and COVID-19 exposure. The FDA and other regulatory agencies issued EUAs for COVID-19 treatments and vaccines based on limited data. Clinical trials matching software helped identify patients who could potentially benefit from these treatments and provided real-world data to support EUA decisions. The pandemic heightened awareness of the importance of clinical trials and matching software. This increased recognition is expected to drive continued adoption of these technologies even after the pandemic subsides. Telemedicine and remote patient engagement, which became crucial during the pandemic, will continue to be integrated into clinical trials. Matching software will play a pivotal role in connecting patients with trials while ensuring remote monitoring and data collection. The experience gained during the pandemic will better prepare the healthcare industry to respond quickly to future health crises. Clinical trials matching software will remain an essential tool for accelerating trial recruitment. Patients have become more proactive in seeking clinical trial opportunities, and matching software will continue to empower them with information and access to trials that align with their health profiles.
Key Market Challenges
Data Privacy and Security Concerns
One of the foremost challenges in the clinical trials matching software market pertains to data privacy and security. Handling sensitive patient data, including medical records and genetic information, requires stringent adherence to privacy regulations such as HIPAA in the United States and GDPR in Europe. Ensuring data security and complying with these regulations can be a complex and costly endeavor for software providers.
Interoperability with Healthcare Systems
Integrating clinical trials matching software with existing healthcare systems, including electronic health records (EHRs), is essential for efficient patient recruitment. However, achieving seamless interoperability remains a significant challenge due to diverse data formats, system compatibility issues, and varying standards across healthcare organizations.
Regulatory Compliance
The clinical trials industry is subject to strict regulatory oversight by agencies like the FDA and EMA. Clinical trials matching software must adhere to evolving regulatory requirements, including data integrity, audit trails, and electronic signatures. Achieving and maintaining compliance can be resource-intensive for software providers.
Ethical Considerations
The ethical aspects of patient recruitment are critical. Ensuring informed consent, minimizing potential biases in participant selection, and addressing disparities in access to trials are ethical challenges faced by clinical trials matching software providers. Ethical considerations also extend to ensuring that patients fully understand the implications of trial participation.
Key Market Trends
Artificial Intelligence and Machine Learning Integration
The integration of artificial intelligence (AI) and machine learning (ML) is set to be a defining trend in the clinical trials matching software market. AI algorithms are becoming increasingly adept at processing vast datasets, identifying potential trial candidates, and predicting patient responses to treatments. ML-driven tools will streamline patient recruitment and optimize trial designs, ultimately accelerating drug development.
Real-Time Data Analytics
The demand for real-time data analytics in clinical trials is growing rapidly. Clinical trials matching software is evolving to provide researchers with immediate access to trial data, allowing them to make data-driven decisions in real time. This trend will enhance the agility and efficiency of clinical trials.
Patient-Centric Approach
A patient-centric approach is gaining prominence in clinical research. Upcoming trends in clinical trials matching software will prioritize patient engagement and empowerment. Patients will have improved access to trial information, simplified enrollment processes, and tools to monitor their progress throughout the trial.
Genomics and Precision Medicine
The era of precision medicine is firmly upon us. As genomics becomes more central to healthcare, clinical trials matching software will incorporate genetic and molecular data to identify candidates for trials tailored to specific genetic profiles. This trend will be particularly significant in oncology and rare disease research.
Segmental Insights
Deployment Mode Insights
Based on the category of Deployment Mode, the web and cloud sector dominated the revenue share in 2022 and is anticipated to experience the most rapid CAGR during the forecast period. This can be attributed to the advantages of the cloud computing model, which is low-maintenance and doesn't entail ongoing expenses. Since it doesn't necessitate in-house server infrastructure, it leads to reduced development costs, shorter integration times, and accessibility from any location. It also facilitates convenient data sharing and collaboration on diverse projects. In contrast, the on-premises model demands in-house infrastructure, software licensing, IT support, and lengthier integration periods, making it a more expensive and less favored option. However, organizations dealing with highly sensitive data, such as government and financial institutions, may prioritize the security and privacy offered by an on-premises environment.
End-use Insights
The pharmaceutical and biotechnology companies sector secured the largest share of revenue due to the extensive number of clinical trials necessary for product launches. To illustrate, in the United States, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) mandates that pharmaceutical companies must conduct safety and efficacy tests on their drugs and provide evidence to the center before selling them in the country. This evaluation process aids in evaluating the advantages and potential risks associated with these medications.
Concurrently, the Contract Research Organization (CRO) segment is projected to achieve the most rapid CAGR over the forecast period. CROs offer a range of services from drug development to commercialization, pharmacovigilance, and post-approval support for manufacturing organizations operating with limited Research and Development (R&D) budgets. Sponsors, the entities seeking to investigate the safety and effectiveness of their products, engage CROs on a project-by-project basis for conducting clinical trials. Organizations that cannot afford to conduct extensive clinical trials themselves increasingly opt to outsource these services. Consequently, there is a surging demand for CROs in the market.
Regional Insights
In 2022, North America took the lead in the market, securing the highest revenue share. This can be attributed to the increased adoption of clinical trials matching software by pharmaceutical and biotechnology companies in the United States. Additionally, the region boasts a robust and well-established pharmaceutical industry, with many companies investing in the development of clinical trials matching software, which is a key driver of market growth. Furthermore, the regulatory environment in North America is conducive to the advancement and commercialization of clinical trial matching software. Various initiatives related to Information Technology (IT) and Artificial Intelligence (AI)-based solutions, coupled with a higher adoption of Clinical Trial Management Systems (CTMS) and patient matching software, are contributing to market expansion in the region.
Conversely, the Asia Pacific region is poised to experience the swiftest CAGR in the upcoming forecast period. This is primarily due to the presence of a substantial patient pool in the region, which facilitates streamlined patient recruitment processes. A multitude of organizations are also looking to establish their Research and Development (R&D) activities in the Asia Pacific, further bolstering market growth. This growth can be attributed to the increasing number of IT healthcare projects, the flourishing economy, and an overall enhancement of healthcare infrastructure, particularly in developing Asian countries such as China and India.
Key Market Players
IBM Clinical Development
Antidote Technologies Inc
Ofni Systems Inc
SSS International Clinical Research GmbH
CLARIO
Advarra Inc
ArisGlobal LLC
Bsi Business Systems Integration AG
Teckro Ltd
Clinical Trials Mobile Application
Report Scope:
In this report, the Global Clinical Trials Matching Software Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Clinical Trials Matching Software Market, By Deployment Mode:
- Web & Cloud-based
- On-premises
- Clinical Trials Matching Software Market, By End-use:
- Pharmaceutical & Biotechnology Companies
- CROs
- Medical Device Firms
- Clinical Trials Matching Software Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Company Profiles: Detailed analysis of the major companies present in the Global Clinical Trials Matching Software Market.
Available Customizations:
Global Clinical Trials Matching Software market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. SERVICE OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
5.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Deployment Mode
5.3.2. By End-use
5.3.3. By Region
6. NORTH AMERICA CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
6.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Clinical Trials Matching Software Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Deployment Mode
6.3.1.2.2. By End-use
6.3.2. Canada Clinical Trials Matching Software Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Deployment Mode
6.3.2.2.2. By End-use
6.3.3. Mexico Clinical Trials Matching Software Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Deployment Mode
6.3.3.2.2. By End-use
7. EUROPE CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
7.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Clinical Trials Matching Software Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Deployment Mode
7.3.1.2.2. By End-use
7.3.2. United Kingdom Clinical Trials Matching Software Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Deployment Mode
7.3.2.2.2. By End-use
7.3.3. France Clinical Trials Matching Software Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Deployment Mode
7.3.3.2.2. By End-use
7.3.4. Italy Clinical Trials Matching Software Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Deployment Mode
7.3.4.2.2. By End-use
7.3.5. Spain Clinical Trials Matching Software Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Deployment Mode
7.3.5.2.2. By End-use
8. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
8.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Clinical Trials Matching Software Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Deployment Mode
8.3.1.2.2. By End-use
8.3.2. Japan Clinical Trials Matching Software Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Deployment Mode
8.3.2.2.2. By End-use
8.3.3. India Clinical Trials Matching Software Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Deployment Mode
8.3.3.2.2. By End-use
8.3.4. Australia Clinical Trials Matching Software Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Deployment Mode
8.3.4.2.2. By End-use
8.3.5. South Korea Clinical Trials Matching Software Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Deployment Mode
8.3.5.2.2. By End-use
9. SOUTH AMERICA CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
9.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Clinical Trials Matching Software Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Deployment Mode
9.3.1.2.2. By End-use
9.3.2. Argentina Clinical Trials Matching Software Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Deployment Mode
9.3.2.2.2. By End-use
9.3.3. Colombia Clinical Trials Matching Software Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Deployment Mode
9.3.3.2.2. By End-use
10. MIDDLE EAST AND AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
10.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Clinical Trials Matching Software Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Deployment Mode
10.3.1.2.2. By End-use
10.3.2. Saudi Arabia Clinical Trials Matching Software Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Deployment Mode
10.3.2.2.2. By End-use
10.3.3. UAE Clinical Trials Matching Software Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Deployment Mode
10.3.3.2.2. By End-use
10.3.4. Kuwait Clinical Trials Matching Software Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Deployment Mode
10.3.4.2.2. By End-use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. IBM Clinical Development
14.6.2. Antidote Technologies Inc
14.6.3. Ofni Systems Inc
14.6.4. SSS International Clinical Research GmbH
14.6.5. CLARIO
14.6.6. Advarra Inc
14.6.7. ArisGlobal LLC
14.6.8. Bsi Business Systems Integration AG
14.6.9. Teckro Ltd
14.6.10. Clinical Trials Mobile Application
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
5.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Deployment Mode
5.3.2. By End-use
5.3.3. By Region
6. NORTH AMERICA CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
6.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Clinical Trials Matching Software Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Deployment Mode
6.3.1.2.2. By End-use
6.3.2. Canada Clinical Trials Matching Software Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Deployment Mode
6.3.2.2.2. By End-use
6.3.3. Mexico Clinical Trials Matching Software Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Deployment Mode
6.3.3.2.2. By End-use
7. EUROPE CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
7.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Clinical Trials Matching Software Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Deployment Mode
7.3.1.2.2. By End-use
7.3.2. United Kingdom Clinical Trials Matching Software Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Deployment Mode
7.3.2.2.2. By End-use
7.3.3. France Clinical Trials Matching Software Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Deployment Mode
7.3.3.2.2. By End-use
7.3.4. Italy Clinical Trials Matching Software Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Deployment Mode
7.3.4.2.2. By End-use
7.3.5. Spain Clinical Trials Matching Software Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Deployment Mode
7.3.5.2.2. By End-use
8. ASIA-PACIFIC CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
8.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Clinical Trials Matching Software Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Deployment Mode
8.3.1.2.2. By End-use
8.3.2. Japan Clinical Trials Matching Software Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Deployment Mode
8.3.2.2.2. By End-use
8.3.3. India Clinical Trials Matching Software Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Deployment Mode
8.3.3.2.2. By End-use
8.3.4. Australia Clinical Trials Matching Software Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Deployment Mode
8.3.4.2.2. By End-use
8.3.5. South Korea Clinical Trials Matching Software Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Deployment Mode
8.3.5.2.2. By End-use
9. SOUTH AMERICA CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
9.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Clinical Trials Matching Software Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Deployment Mode
9.3.1.2.2. By End-use
9.3.2. Argentina Clinical Trials Matching Software Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Deployment Mode
9.3.2.2.2. By End-use
9.3.3. Colombia Clinical Trials Matching Software Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Deployment Mode
9.3.3.2.2. By End-use
10. MIDDLE EAST AND AFRICA CLINICAL TRIALS MATCHING SOFTWARE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Deployment Mode (Web & Cloud-based, On-premises)
10.2.2. By End-use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Clinical Trials Matching Software Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Deployment Mode
10.3.1.2.2. By End-use
10.3.2. Saudi Arabia Clinical Trials Matching Software Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Deployment Mode
10.3.2.2.2. By End-use
10.3.3. UAE Clinical Trials Matching Software Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Deployment Mode
10.3.3.2.2. By End-use
10.3.4. Kuwait Clinical Trials Matching Software Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Deployment Mode
10.3.4.2.2. By End-use
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. IBM Clinical Development
14.6.2. Antidote Technologies Inc
14.6.3. Ofni Systems Inc
14.6.4. SSS International Clinical Research GmbH
14.6.5. CLARIO
14.6.6. Advarra Inc
14.6.7. ArisGlobal LLC
14.6.8. Bsi Business Systems Integration AG
14.6.9. Teckro Ltd
14.6.10. Clinical Trials Mobile Application
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
